Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 128.22-6.71-52.3565.67-8.91

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 128.22 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67
Mar2020-8.91

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67
Positive
Mar2020 -8.91 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹141.5 Cr 10.2% -14.6% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,622.0 Cr -0.7% -3.6% -13.1% Stock Analytics
DIVIS LABORATORIES ₹159,536.0 Cr 0.3% -5.5% 22.4% Stock Analytics
CIPLA ₹125,468.0 Cr -0.8% 4.1% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,162.0 Cr 1.1% -0.5% 5.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,874.0 Cr -0.8% 2.3% -8.1% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

10.2%

-14.6%

19.1%

SENSEX

0.8%

0.2%

-2%


You may also like the below Video Courses